Risk of CIN2+ in women aged >60 years with abnormal cervical cancer screening: a multicenter retrospective cohort study from the Thai Gynecologic Cancer Society research group
Journal of Gynecologic Oncology · 2025
DOI: 10.3802/jgo.2025.36.e83 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Nida Jareemit und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gynaecologic Oncology Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Uterine Cervical Dysplasia. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Siriraj Foundation.
Abstract (Originalsprache)
OBJECTIVE: To study patterns of abnormal cervical cancer screening in women aged >60 years and explore the risk and predictors of cervical intraepithelial neoplasia grade 2 or worse (CIN2+). METHODS: This retrospective cohort study examined 1,596 women aged >60 years with abnormal cervical cancer screening results from eight Thai cancer centers. Those who underwent hysterectomy were excluded. Patient characteristics, previous and current cervical cancer screening results, and histopathology data were collected and analyzed. RESULTS: Mean age was 68.2±7.2 years. The abnormal screening results were normal cytology with positive high-risk human papillomavirus (0.9%), atypical squamous cells of undetermined significance (37.7%), low-grade squamous intraepithelial lesion (12%), atypical squamous cell cannot exclude high-grade lesion (11.7%), high-grade squamous intraepithelial lesion (12.7%), atypical glandular cell (20.1%), squamous cell carcinoma (4.3%), and adenocarcinoma (0.7%). Risk of CIN2+ in women with abnormal screening was 17.9% (95% confidence interval [CI]=16.1-19.8); among those with available histopathology, the risk was 28.8% (95% CI=26.1-31.7). Univariable logistic regression showed that age >70 years, sexual activity within 1 year, previous abnormal/no screening, previous CIN2+ pathology, presence of symptoms, and high-grade cytology were significant predictors of CIN2+. In the multivariable analysis, lack of previous screening (adjusted odds ratio=4.05; 95% CI=1.91-8.60; p 60 years should be individualized based on their risk factors, particularly for those who have never been screened.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynaecologic Oncology Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Department of Gynecologic Oncology, National Cancer Institute, Bangkok, Thailand.
- Department of Obstetrics and Gynecology, Rajavithi Hospital College of Medicine, Rangsit University, Bangkok, Thailand.
- Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
- Obstetrics and Gynecology Section, MedPark Hospital, Bangkok, Thailand.
- Princess Srisavangavadhana Faculty of Medicine, Department of Obstetrics and Gyneacology, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.
ORCID-Profile: Nida Jareemit, Warangkana Kolaka, Jitima Tiyayon, Siriwan Tangjitgamol, Perapong Inthasorn, Ruai Kittikhun, Nuttavut Kantathavorn
Förderung
- Siriraj Foundation
Zitieren
APA
Jareemit, N., Kolaka, W., Tiyayon, J., Tangjitgamol, S., Inthasorn, P., Kittikhun, R., & Kantathavorn, N. (2025). Risk of CIN2+ in women aged >60 years with abnormal cervical cancer screening: a multicenter retrospective cohort study from the Thai Gynecologic Cancer Society research group. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e83
Vancouver
Jareemit N, Kolaka W, Tiyayon J, Tangjitgamol S, Inthasorn P, Kittikhun R, et al. Risk of CIN2+ in women aged >60 years with abnormal cervical cancer screening: a multicenter retrospective cohort study from the Thai Gynecologic Cancer Society research group. Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e83
BibTeX
@article{Jareemit2025,
author = {Jareemit, Nida and Kolaka, Warangkana and Tiyayon, Jitima and Tangjitgamol, Siriwan and Inthasorn, Perapong and Kittikhun, Ruai and Kantathavorn, Nuttavut},
title = {Risk of CIN2+ in women aged >60 years with abnormal cervical cancer screening: a multicenter retrospective cohort study from the Thai Gynecologic Cancer Society research group},
journal = {Journal of Gynecologic Oncology},
year = {2025},
doi = {10.3802/jgo.2025.36.e83}
}
EUVIMED